Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Open accessAbstract
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory A(1) receptors (A1R) and facilitatory A(2A) receptors (A2AR), mostly controlling excitatory glutamatergic synapses: A1R impose a tonic brake on excitatory transmission, whereas A2AR are selectively engaged to promote synaptic plasticity phenomena. This neuromodulatory role of adenosine is strikingly similar to the role of adenosine in the control of brain disorders; thus, A1R mostly act as a hurdle that needs to be overcame to begin neurodegeneration and, accordingly, A1R only effectively control neurodegeneration if activated in the temporal vicinity of brain insults; in contrast, the blockade of A2AR alleviates the long-term burden of brain disorders in different neurodegenerative conditions such as ischemia, epilepsy, Parkinson's or Alzheimer's disease and also seem to afford benefits in some psychiatric conditions. In spite of this qualitative agreement between neuromodulation and neuroprotection by A1R and A2AR, it is still unclear if the role of A1R and A2AR in the control of neuroprotection is mostly due to the control of glutamatergic transmission, or if it is instead due to the different homeostatic roles of these receptors related with the control of metabolism, of neuron-glia communication, of neuroinflammation, of neurogenesis or of the control of action of growth factors. In spite of this current mechanistic uncertainty, it seems evident that targeting adenosine receptors might indeed constitute a novel strategy to control the demise of different neurological and psychiatric disorders.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · see citing works
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · see citing works
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · see citing works
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,973 · see citing works
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 3,949 · see citing works
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
van Praag, H., Kempermann, G., & Gage, F. H. (1999) · Nature Neuroscience · doi:10.1038/6368 · Cited by 3,880 · see citing works
Paxinos, G. (1985) · Cited by 3,715 · see citing works
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592 · see citing works
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853 · see citing works
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,644 · see citing works
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 4× · see citing works
“receptors should be the main targets of caffeine [4,8], there is evidence that caffeine can affect different other molecular targets”
BackgroundInfluentialInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426 · see citing works
Epilepsy: A Comprehensive Textbook
(2008) · JAMA · doi:10.1001/jama.300.4.443-a · Cited by 2,355 · see citing works
Long-Distance Neuronal Migration in the Adult Mammalian Brain
Lois, C., & Álvarez-Buylla, A. (1994) · Science · doi:10.1126/science.8178174 · Cited by 2,331 · see citing works
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178 · see citing works
Neurogenesis in the adult is involved in the formation of trace memories
Shors, T. J., Miesegaes, G. R., Beylin, A. V., Zhao, M., Rydel, T. A., & Gould, E. (2001) · Nature · doi:10.1038/35066584 · Cited by 2,014 · see citing works
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005 · see citing works
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · see citing works
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · see citing works
Manic-Depressive Insanity and Paranoia.
(1921) · JAMA · doi:10.1001/jama.1921.02630330070026 · Cited by 1,612 · see citing works
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585 · see citing works
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559 · see citing works
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works
Drury, A. N., & Szent‐Györgyi, A. (1929) · The Journal of Physiology · doi:10.1113/jphysiol.1929.sp002608 · Cited by 1,493 · see citing works
Altman, J. (1969) · The Journal of Comparative Neurology · doi:10.1002/cne.901370404 · Cited by 1,489 · see citing works
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463 · see citing works
Carlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,351 · see citing works
Manic Depressive Insanity and Paranoia
Kraepelin, E. (1921) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-192104000-00057 · Cited by 1,327 · see citing works
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233 · see citing works
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · see citing works
Rat forebrain neurogenesis and striatal neuron replacement after focal stroke
Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N., & Ferriero, D. M. (2002) · Annals of Neurology · doi:10.1002/ana.10393 · Cited by 1,020 · see citing works
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z.-Y., Lee, F. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-04.2005 · Cited by 1,013 · see citing works
A unified hypothesis on the lineage of neural stem cells
Álvarez-Buylla, A., García‐Verdugo, J. M., & Tramontin, A. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067582 · Cited by 995 · see citing works
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 983 · see citing works
Adult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964 · see citing works
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · see citing works
Sattin, A., & Rall, T. W. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15197-3 · Cited by 893 · see citing works
The role of adenosine in the regulation of coronary blood flow.
Berne, R. M. (1980) · Circulation Research · doi:10.1161/01.res.47.6.807 · Cited by 884 · see citing works
Purinergic signalling in neuron–glia interactions
Fields, R. D., & Burnstock, G. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1928 · Cited by 852 · see citing works
VEGF links hippocampal activity with neurogenesis, learning and memory
Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., & During, M. J. (2004) · Nature Genetics · doi:10.1038/ng1395 · Cited by 850 · see citing works
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815 · see citing works
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801 · see citing works
Neurogenesis in the Adult Brain
Gage, F. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00612.2002 · Cited by 796 · see citing works
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
Latini, S., & Pedata, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00607.x · Cited by 779 · see citing works
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · see citing works
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749 · see citing works
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 1× · see citing works
“To balance early changes in inhibitory dopaminergic tonus, compensatory mechanisms, such as plastic adaptations in the cortico-striatal pathway [208–210], probably delaymotor impairment and justify the existence of a pre-symptomatic period [211] preceding the gradual appearance of symptoms.”
BackgroundSitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697 · see citing works
Fredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 694 · see citing works
Self-citationProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · see citing works
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 649 · see citing works
Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons
Song, H., Stevens, C. F., & Gage, F. H. (2002) · Nature Neuroscience · doi:10.1038/nn844 · Cited by 642 · see citing works
Kronenberg, G., Reuter, K., Steiner, B., Brandt, M. D., Jessberger, S., Yamaguchi, M., & Kempermann, G. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10945 · Cited by 640 · see citing works
Cunha, R. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00034-6 · Cited by 632 · see citing works
Self-citationChen, J., Xu, K., Petzer, J. P., Staal, R. G. W., Xu, Y., Beilstein, M. A., Sonsalla, P. K., Castagnoli, K., Castagnoli, N. J., & Schwarzschild, M. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 608 · see citing works
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 600 · see citing works
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 591 · see citing works
Self-citationNeurogenesis in the Adult Brain: New Strategies for Central Nervous System Diseases
Lie, D. C., Song, H., Colamarino, S. A., Ming, G., & Gage, F. H. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121631 · Cited by 589 · see citing works
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 585 · see citing works
Olson, A. K., Eadie, B. D., Ernst, C., & Christie, B. R. (2006) · Hippocampus · doi:10.1002/hipo.20157 · Cited by 565 · see citing works
A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D. G., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557 · see citing works
Heurteaux, C., Lauritzen, I., Widmann, C., & Lazdunski, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4666 · Cited by 553 · see citing works
Ferré, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxé, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 551 · see citing works
Role of brain-derived neurotrophic factor in Huntington's disease
Zuccato, C., & Cattaneo, E. F. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 548 · see citing works
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 540 · see citing works
Self-citationFunctional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534 · see citing works
Adult neurogenesis and neural stem cells of the central nervous system in mammals
Taupin, P., & Gage, F. H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10378 · Cited by 527 · see citing works
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516 · see citing works
Adenosine receptors in the nervous system: pathophysiological implications
Ribeiro, J. A., Sebastião, A. M., & de Mendonça, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00155-7 · Cited by 509 · see citing works
Johansson, B. A., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez‐Llort, L., Escorihuela, R. M., Fernández‐Teruel, A., Wiesenfeld‐Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 506 · see citing works
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R. P., Terasmaa, A., Hansson, A. C., Watson, S. J., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 499 · see citing works
Neurogenesis in adult primate neocortex: an evaluation of the evidence
RAKIC, P. T. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn700 · Cited by 491 · see citing works
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 487 · see citing works
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 484 · see citing works
Thompson, S. M., Haas, H. L., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019168 · Cited by 483 · see citing works
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
During, M. J., & Spencer, D. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320504 · Cited by 478 · see citing works
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S., & Li, X. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 475 · see citing works
Molecular Targets for Antiepileptic Drug Development
Meldrum, B. S., & Rogawski, M. A. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 473 · see citing works
Quality of Life in Panic Disorder
Markowitz, J. S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110026004 · Cited by 471 · see citing works
Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 461 · see citing works
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440 · see citing works
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind ) mice
Jin, K., Galván, V., Xie, L., Mao, X. O., Gorostiza, O. F., Bredesen, D. E., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403678101 · Cited by 433 · see citing works
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D. J., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K. A., Fuxé, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432 · see citing works
Adenosine and the concept of ‘retaliatory metabolites’
Newby, A. C. (1984) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(84)90176-2 · Cited by 430 · see citing works
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428 · see citing works
BIOCHEMISTRY, LOCALIZATION AND FUNCTIONAL ROLES OF ECTO-NUCLEOTIDASES IN THE NERVOUS SYSTEM
Zimmermann, H. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00026-3 · Cited by 426 · see citing works
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & Raymond, L. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 410 · see citing works
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R. M., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 393 · see citing works
Self-citationScanziani, M., Capogna, M., Gähwiler, B., & Thompson, S. (1992) · Neuron · doi:10.1016/0896-6273(92)90244-8 · Cited by 386 · see citing works
Axon pathology in neurological disease: a neglected therapeutic target
Coleman, M. P., & Perry, V. H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02255-5 · Cited by 383 · see citing works
GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379 · see citing works
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.023 · Cited by 376 · see citing works
Self-citationTanapat, P., Hastings, N. B., Rydel, T. A., Galea, L. A. M., & Gould, E. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1297 · Cited by 376 · see citing works
Dall'Igna, O. P. P., Neto, P. F., Gomes, M. W. S., Souza, D. O., Cunha, R. A., & Lara, D. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372 · see citing works
Self-citationThe effect of adenosine on the release of the transmitter from the phrenic nerve of the rat
Ginsborg, B. L., & Hirst, G. D. S. (1972) · The Journal of Physiology · doi:10.1113/jphysiol.1972.sp009916 · Cited by 369 · see citing works
Ferré, S., Karcz‐Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxé, K., Goldberg, S. R., Lluı́s, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365 · see citing works
GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
Arenas, E., Trupp, M., Åkerud, P., & Ibáñez, C. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90024-1 · Cited by 363 · see citing works
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 358 · see citing works
Self-citationDoes caffeine intake protect from Alzheimer's disease?
Maia, L., & de Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357 · see citing works
Wu, L.-G., & Saggau, P. (1994) · Neuron · doi:10.1016/0896-6273(94)90321-2 · Cited by 348 · see citing works
Nisenbaum, E., & Wilson, C. J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04449.1995 · Cited by 348 · see citing works
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347 · see citing works
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
Keshavan, M. S., TANDON, R., Boutros, N. N., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 345 · see citing works
Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338 · see citing works
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338 · see citing works
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334 · see citing works
Lindström, L., Gefvert, O., Hagberg, G., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00109-2 · Cited by 332 · see citing works
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease
Bara‐Jimenez, W., Sherzai, A. Z., Dimitrova, T. D., Favit, A., Bibbiani, F., Gillespie, M., Morris, M. J., Mouradian, M. M., & Chase, T. N. (2003) · Neurology · doi:10.1212/01.wnl.0000073136.00548.d4 · Cited by 328 · see citing works
Tsutsui, S., Schnermann, J. B., Noorbakhsh, F., Henry, S. D., Yong, V. W., Winston, B. W., Warren, K. G., & Power, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 324 · see citing works
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 322 · see citing works
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314 · see citing works
The corticostriatal pathway in Huntington's disease
Cepeda, C., Wu, N.-P., André, V. M., Cummings, D. M., & LEVINE, M. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.001 · Cited by 309 · see citing works
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308 · see citing works
Adenosine signaling and function in glial cells
Boison, D., Chen, J., & Fredholm, B. B. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.131 · Cited by 306 · see citing works
Post, R. M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.003 · Cited by 302 · see citing works
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
Emborg, M. E., Ma, S. Y., Mufson, E. J., Levey, A. I., Taylor, M. D., Brown, W. D., Holden, J. E., & Kordower, J. H. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981116)401:2 · Cited by 298 · see citing works
Rudolphi, K. A., & Schubert, P. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2011-5_43 · Cited by 296 · see citing works
Localized striatal delivery of GDNF as a treatment for Parkinson disease
Kirik, D., Georgievska, B., & Björklund, A. (2004) · Nature Neuroscience · doi:10.1038/nn1175 · Cited by 289 · see citing works
Nemeroff, C. B., & Owens, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn943 · Cited by 282 · see citing works
Boyd, J. G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00183-3 · Cited by 281 · see citing works
Lei, W., Jiao, Y., Mar, N. D., & Reiner, A. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277 · see citing works
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors
Higley, M. J., & Sabatini, B. L. (2010) · Nature Neuroscience · doi:10.1038/nn.2592 · Cited by 271 · see citing works
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., Lubitz, D. K. J. E. V., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263 · see citing works
Wylen, D. G. L. V., Park, T. S., Rubio, R., & Berne, R. M. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.97 · Cited by 261 · see citing works
Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia
Potter, D., Summerfelt, A. T., Gold, J. M., & Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj050 · Cited by 260 · see citing works
Neuroprotection by caffeine and adenosine A 2A receptor blockade of β ‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 255 · see citing works
Self-citationFerré, S., Quiroz, C., Woods, A. S., Cunha, R. A., Popoli, P., Ciruela, F., Lluı́s, C., Franco, R., Azdad, K., & Schiffmann, S. N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480108 · Cited by 254 · see citing works
Self-citationAdenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
Schiffmann, S., & Vanderhaeghen, J. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01080.1993 · Cited by 253 · see citing works
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252 · see citing works
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice
Li, T., Ren, G., Lusardi, T. A., Wilz, A., Lan, J. Q., Iwasato, T., Itohara, S., Simon, R. P., & Boison, D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33737 · Cited by 251 · see citing works
Antiparkinsonian effect of a new selective adenosine A2Areceptor antagonist in MPTP-treated monkeys
Grondin, R., Bédard, P. J., Tahar, A. H., Grégoire, L., Mori, A., & Kase, H. (1999) · Neurology · doi:10.1212/wnl.52.8.1673 · Cited by 250 · see citing works
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248 · see citing works
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. G. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7350 · Cited by 248 · see citing works
Adenosine-dopamine interactions in the ventral striatum
Ferré, S. (1997) · Psychopharmacology · doi:10.1007/s002130050380 · Cited by 246 · see citing works
Adenosine kinase, epilepsy and stroke: mechanisms and therapies
Boison, D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.008 · Cited by 243 · see citing works
Cui, Q., Yip, H. K.-F., Zhao, R. C., So, K., & Harvey, A. R. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00037-4 · Cited by 243 · see citing works
Prediger, R. D., Batista, L. C., & Takahashi, R. N. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.012 · Cited by 240 · see citing works
Chen, J., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., Geiger, J. D., Lopes, L. V., & de Mendonça, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.09.002 · Cited by 238 · see citing works
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1378 · Cited by 236 · see citing works
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 233 · see citing works
Self-citationThe electrophysiology of adenosine in the mammalian central nervous system
Greene, R. W., & Haas, H. L. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90005-l · Cited by 233 · see citing works
The adenosine kinase hypothesis of epileptogenesis
Boison, D. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.002 · Cited by 224 · see citing works
Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease
Ikeda, K., Kurokawa, M., Aoyama, S., & Kuwana, Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00694.x · Cited by 224 · see citing works
Chapter 11 Adenosine and Neuroprotection
Fredholm, B. B. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60723-0 · Cited by 218 · see citing works
Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi‐Albedi, F., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218 · see citing works
Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K., & Kuwana, Y. (1999) · Psychopharmacology · doi:10.1007/s002130051146 · Cited by 216 · see citing works
Magavi, S. S. P., Mitchell, B. D., Szentirmai, O., Carter, B. S., & Macklis, J. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2250-05.2005 · Cited by 215 · see citing works
Mishra, S. K., Braun, N., Shukla, V., Füllgrabe, M., Schomerus, C., Korf, H., Gachet, C., Ikehara, Y., Sévigny, J., Robson, S. C., et al. (2006) · Development · doi:10.1242/dev.02233 · Cited by 215 · see citing works
Silinsky, E. M. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015019 · Cited by 214 · see citing works
Symptoms and duration of the prodromal phase in parkinson's disease
Gonera, E. G., Hof, M. V., Berger, H. J. C., van Weel, C., & Horstink, M. W. I. M. (1997) · Movement Disorders · doi:10.1002/mds.870120607 · Cited by 212 · see citing works
Jin, K., LaFevre-Bernt, M. A., Sun, Y., Chen, S., Gafni, J., Crippen, D., Logvinova, A. V., Ross, C. A., Greenberg, D. A., & Ellerby, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506375102 · Cited by 212 · see citing works
Sleep deprivation suppresses neurogenesis in the adult hippocampus of rats
Guzmán-Marı́n, R., Suntsova, N., Methippara, M. M., Greiffenstein, R., Szymusiak, R. S., & McGinty, D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04376.x · Cited by 210 · see citing works
Sawai, H., Clarke, D. B., Kittlerová, P., Bray, G. M., & Aguayo, A. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03887.1996 · Cited by 209 · see citing works
Gouder, N., Fritschy, J., & Boison, D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.03603.x · Cited by 208 · see citing works
Li, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1227 · Cited by 207 · see citing works
Kirik, D., Rosenblad, C., & Björklund, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00274.x · Cited by 206 · see citing works
Facilitated Glutamatergic Transmission in the Striatum of D2Dopamine Receptor-Deficient Mice
Cepeda, C., Hurst, R. S., Altemus, K. L., Flores‐Hernández, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., et al. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.659 · Cited by 203 · see citing works
Rebola, N., Canas, P. M., Oliveira, C. R., & Cunha, R. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.014 · Cited by 202 · see citing works
Self-citationScholz, K. P., & Miller, R. J. (1992) · Neuron · doi:10.1016/0896-6273(92)90134-y · Cited by 201 · see citing works
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00034 · Cited by 200 · see citing works
Caffeine dependence syndrome. Evidence from case histories and experimental evaluations
Strain, E. C. (1994) · JAMA · doi:10.1001/jama.272.13.1043 · Cited by 200 · see citing works
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J., & Vaugeois, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704240 · Cited by 199 · see citing works
Mitchell, J., Lupica, C. R., & Dunwiddie, T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03439.1993 · Cited by 197 · see citing works
Rodrigues, R. J., Alfaro, T. M., Rebola, N., Oliveira, C. R., & Cunha, R. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02887.x · Cited by 196 · see citing works
Self-citationCaffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
Cao, C., Cirrito, J. R., Lin, X., Wang, L., Verges, D. K., Dickson, A., Mamcarz, M. B., Zhang, C., Mori, T., Arendash, G. W., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1071 · Cited by 195 · see citing works
Fedele, D., Gouder, N., Güttinger, M., Gabernet, L., Scheurer, L., Rülicke, T., Crestani, F., & Boison, D. (2005) · Brain · doi:10.1093/brain/awh555 · Cited by 193 · see citing works
Jin, Y. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7980 · Cited by 193 · see citing works
Ciruela, F., Burgueño, J., Casadó, V., Canals, M., Marcellino, D. J., Goldberg, S. R., Bäder, M., Fuxé, K., Agnati, L. F., Lluís, C., et al. (2004) · Analytical Chemistry · doi:10.1021/ac049295f · Cited by 192 · see citing works
Dunwiddie, T. V., & Haas, H. L. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015907 · Cited by 192 · see citing works
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E. F., Brini, M., & Carafoli, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 192 · see citing works
Lopes, L. V., Cunha, R. A., & Ribeiro, J. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3196 · Cited by 191 · see citing works
Self-citationCaffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · see citing works
Anxiety and depression associated with caffeinism among psychiatric inpatients
Greden, J. F., Fontaine, P., Lubetsky, M. J., & Chamberlin, K. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.963 · Cited by 189 · see citing works
Purinergic mechanisms in epilepsy
Dragunow, M. (1988) · Progress in Neurobiology · doi:10.1016/0301-0082(88)90028-7 · Cited by 187 · see citing works
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R. A., Ferré, S., Vaugeois, J., & Chen, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 187 · see citing works
Self-citationKochanek, P. M., Vagni, V., Janesko, K. L., Washington, C. B., Crumrine, P. K., Garman, R. H., Jenkins, L. W., Clark, R. S. B., Homanics, G. E., Dixon, C. E., et al. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600218 · Cited by 185 · see citing works
Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus
Yoon, K. W., & Rothman, S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-05-01375.1991 · Cited by 184 · see citing works
Angulo-Pueyo, E., Casadó, V., Mallol, J., Canela, E. I., Viñals, F., Ferrer, I., Lluís, C., & Franco, R. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00475.x · Cited by 179 · see citing works
Cui, Q., Lü, Q., So, K., & Yip, H. K.-F. (1999) · PubMed · Cited by 177 · see citing works
RESEARCH ARTICLE: Up‐regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease
Albasanz, J. L., Perez, S., Barrachina, M., Ferrer, I., & Martı́n, M. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00112.x · Cited by 177 · see citing works
Ruitenberg, M. J., Plant, G. W., Hamers, F. P. T., Wortel, J., Blits, B., Dijkhuizen, P. A., Gispen, W. H., Boer, G. J., & Verhaagen, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07045.2003 · Cited by 177 · see citing works
Adenosinergic cardioprotection: Multiple receptors, multiple pathways
Peart, J. N., & Headrick, J. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.004 · Cited by 175 · see citing works
Nucleotide signaling in nervous system development
Zimmermann, H. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0067-4 · Cited by 174 · see citing works
Diógenes, M. J., Fernandes, C. D. C., Sebastião, A. M., & Ribeiro, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4454-03.2004 · Cited by 174 · see citing works
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Takahashi, R. N. (2007) · Frontiers in bioscience · doi:10.2741/2870 · Cited by 173 · see citing works
Fuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 171 · see citing works
Adenosine A1 receptors are crucial in keeping an epileptic focus localized
Fedele, D., Li, T., Lan, J. Q., Fredholm, B. B., & Boison, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.133 · Cited by 170 · see citing works
Lundblad, M., Vaudano, E., & Cenci, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01632.x · Cited by 169 · see citing works
Anoxic preconditioning in hippocampal slices: role of adenosine
Pérez‐Pinzón, M. A., Mumford, P. L., Rosenthal, M., & Sick, T. J. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00311-9 · Cited by 168 · see citing works
Rebola, N., Pinheiro, P. S., Oliveira, C. R., Malva, J. O., & Cunha, R. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03247-5 · Cited by 166 · see citing works
Self-citationSynaptic dysfunction in Huntington's disease: a new perspective
Smith, R., Brundin, P., & Li, J.-Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5084-5 · Cited by 166 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works
Adenosine receptors as drug targets — what are the challenges?
Chen, J., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 899 · see citing works
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783 · see citing works
Molecular Targets of Cannabidiol in Neurological Disorders
Bih, C. I., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M. L., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 582 · see citing works
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557 · see citing works
Neuron–glia interactions in the pathophysiology of epilepsy
Patel, D. C., Tewari, B. P., Chaunsali, L., & Sontheimer, H. W. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0126-4 · Cited by 461 · see citing works
How does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 442 · see citing works
Self-citationAdenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 309 · see citing works
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury
Gaudin, A., Yemişçi, M., Eroğlu, H., Lepêtre‐Mouelhi, S., Türkoğlu, Ö. F., Dönmez‐Demir, B., Caban-Toktas, S., Sargon, M. F., Garcia‐Argote, S., Pieters, G., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.274 · Cited by 261 · see citing works
ATP as a multi-target danger signal in the brain
Rodrigues, R. J., Tomé, Â. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 262 · see citing works
Self-citationGomes, C. A., Ferreira, R., George, J., Sanches, R., Rodrigues, D. I., Gonçalves, N., & Cunha, R. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-16 · Cited by 232 · see citing works
Self-citationAstrocyte immune responses in epilepsy
Aronica, E., Ravizza, T., Zurolo, E., & Vezzani, A. (2012) · Glia · doi:10.1002/glia.22312 · Cited by 208 · see citing works
Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.10.010 · Cited by 201 · see citing works
Burnstock, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.031 · Cited by 200 · see citing works
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Armentero, M., Pinna, A., Ferré, S., Lanciego, J. L., Müller, C. E., & Franco, R. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.004 · Cited by 193 · see citing works
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Hossain, M. A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113365 · Cited by 196 · see citing works
Antonioli, L., Colucci, R., Motta, C. L., Tuccori, M., Awwad, O., Settimo, F. D., Blandizzi, C., & Fornai, M. (2012) · Current Drug Targets · doi:10.2174/138945012800564095 · Cited by 179 · see citing works
Adenosine and inflammation: what's new on the horizon?
Antonioli, L., Csóka, B., Fornai, M., Colucci, R., Kókai, E., Blandizzi, C., & Haskó, G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.010 · Cited by 154 · see citing works
Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
Matos, M., Augusto, E., dos Santos‐Rodrigues, A., Schwarzschild, M. A., Chen, J., Cunha, R. A., & Agostinho, P. M. (2012) · Glia · doi:10.1002/glia.22290 · Cited by 148 · see citing works
Self-citationThe role of adenosine receptors in mood and anxiety disorders
van Calker, D., Biber, K. P. H., Domschke, K., & Serchov, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14841 · Cited by 142 · see citing works
Guanosine and its role in neuropathologies
Bettio, L. E. B., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9509-4 · Cited by 141 · see citing works
Li, P., Rial, D., Canas, P. M., Yoo, J.-H., Li, W., Zhou, X., Wang, Y., van Westen, G. J. P., Payen, M.-P., Augusto, E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.182 · Cited by 139 · see citing works
Self-citationAdenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 137 · see citing works
Regulation of neuronal communication by G protein‐coupled receptors
Huang, Y., & Thathiah, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.007 · Cited by 133 · see citing works
Matos, M., Augusto, E., Machado, N. J., Santos-Rodrigues, A. D., Cunha, R., & Agostinho, P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120469 · Cited by 132 · see citing works
Self-citationKoscsó, B., Csóka, B., Selmeczy, Z., Himer, L., Pacher, P., Virág, L., & Haskó, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101224 · Cited by 129 · see citing works
Matos, M., Augusto, E., Agostinho, P. M., Cunha, R. A., & Chen, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1828-13.2013 · Cited by 127 · see citing works
Self-citationCerebral Blood Flow Measurements in Adults: A Review on the Effects of Dietary Factors and Exercise
Joris, P., Mensink, R., Adam, T., & Liu, T. T. (2018) · Nutrients · doi:10.3390/nu10050530 · Cited by 116 · see citing works
Adenosine receptor neurobiology: overview
Chen, J.-F., Lee, C.-F., & Chern, Y. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00001-5 · Cited by 119 · see citing works
Pathological overproduction: the bad side of adenosine
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13763 · Cited by 117 · see citing works
Pandolfo, P., Machado, N. J., Köfalvi, A., Takahashi, R. N., & Cunha, R. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.011 · Cited by 118 · see citing works
Self-citationLopes, J. P., Pliássova, A., & Cunha, R. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.008 · Cited by 118 · see citing works
Self-citationZhu, Y., Hu, X., Shi, S., Gao, R., Huang, H.-L., Zhu, Y., Lv, X., & Yao, T. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.12.015 · Cited by 105 · see citing works
History and Perspectives of A2AAdenosine Receptor Antagonists as Potential Therapeutic Agents
Preti, D., Baraldi, P. G., Moorman, A. R., Borea, P. A., & Varani, K. (2015) · Medicinal Research Reviews · doi:10.1002/med.21344 · Cited by 100 · see citing works
Dal-Cim, T. A., Ludka, F. K., Martins, W. C., Reginato, C., Parada, E., Egea, J., López, M. G., & Tasca, C. I. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12324 · Cited by 100 · see citing works
The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
Huang, Y., Todd, N., & Thathiah, A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.02.001 · Cited by 99 · see citing works
Comorbidities in Neurology: Is adenosine the common link?
Boison, D., & Aronica, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.031 · Cited by 94 · see citing works
The Role of Adenosine Receptors in Psychostimulant Addiction
Ballesteros-Yáñez, I., Castillo, C. A., Merighi, S., & Gessi, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00985 · Cited by 80 · see citing works
Canzian, J., Fontana, B. D., de Quadros, V. A., & Rosemberg, D. B. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.018 · Cited by 89 · see citing works
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 88 · see citing works
Gonçalves, N., Simões, A., Cunha, R. A., & de Almeida, L. P. (2013) · Annals of Neurology · doi:10.1002/ana.23866 · Cited by 90 · see citing works
Self-citationCaetano, L. M., Pinheiro, H., Patrício, P., Mateus‐Pinheiro, A., Alves, N. D., Coimbra, B., Baptista, F. I., Henriques, S. N., Cunha, C., Santos, A. R. S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.173 · Cited by 86 · see citing works
Self-citationShariatgorji, M., Strittmatter, N., Nilsson, A., Källback, P., Alvarsson, A., Zhang, X., Vallianatou, T., Svenningsson, P., Goodwin, R. J. A., & Andrén, P. E. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.05.004 · Cited by 85 · see citing works
Neurodegeneration and Neuroprotection in Glaucoma.
Gauthier, A. C., & Liu, J. (2016) · Europe PMC (PubMed Central) · Cited by 85 · see citing works
Madeira, M. H., Boia, R., Elvas, F., Martins, T., Cunha, R. A., Ambrósio, A. F., & Santiago, A. R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.11.005 · Cited by 83 · see citing works
Self-citationBeneficial and detrimental role of adenosine signaling in diseases and therapy
Liu, H., & Xia, Y. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00350.2015 · Cited by 85 · see citing works
Aires, I. D., Boia, R., Rodrigues‐Neves, A. C., Madeira, M. H., Marques, C., Ambrósio, A. F., & Santiago, A. R. (2019) · Glia · doi:10.1002/glia.23579 · Cited by 85 · see citing works
Madeira, M. H., Elvas, F., Boia, R., Gonçalves, F. Q., Cunha, R. A., Ambrósio, A. F., & Santiago, A. R. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0333-5 · Cited by 83 · see citing works
Self-citationMadeira, M. H., Boia, R., Ambrósio, A. F., & Santiago, A. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/4761081 · Cited by 84 · see citing works
di Biase, L., Pecoraro, P. M., Carbone, S. P., Caminiti, M. L., & Lazzaro, V. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134427 · Cited by 86 · see citing works
Challenges of BDNF-based therapies: From common to rare diseases
Miranda‐Lourenço, C., Ribeiro‐Rodrigues, L., Fonseca‐Gomes, J., Tanqueiro, S. R., Belo, R. F., Ferreira, C. B., Rei, N., Ferreira-Manso, M., de Almeida-Borlido, C., Costa-Coelho, T., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105281 · Cited by 83 · see citing works
Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
Santiago, A. R., Baptista, F. I., Santos, P. F., Cristóvão, G., Ambrósio, A. F., Cunha, R. A., & Gomes, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/465694 · Cited by 77 · see citing works
Self-citationThe Role of Adenosine Signaling in Headache: A Review
Fried, N. T., Elliott, M. B., & Oshinsky, M. L. (2017) · Brain Sciences · doi:10.3390/brainsci7030030 · Cited by 76 · see citing works
Oncostatin M, an Underestimated Player in the Central Nervous System
Houben, E., Hellings, N., & Broux, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01165 · Cited by 73 · see citing works
Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly
Arosio, B., D’Addario, C., Gussago, C., Casati, M., Tedone, E., Ferri, E., Nicolini, P., Rossi, P. D., Maccarrone, M., & Mari, D. (2014) · BioMed Research International · doi:10.1155/2014/169203 · Cited by 73 · see citing works
Treatment of chronic neuropathic pain: purine receptor modulation
Jacobson, K. A., Giancotti, L. A., Lauro, F., Mufti, F., & Salvemini, D. (2020) · Pain · doi:10.1097/j.pain.0000000000001857 · Cited by 70 · see citing works
Glial adenosine kinase – A neuropathological marker of the epileptic brain
Aronica, E., Sandau, U. S., Iyer, A. M., & Boison, D. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.028 · Cited by 70 · see citing works
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Zarrinmayeh, H., & Territo, P. (2020) · Molecular Imaging · doi:10.1177/1536012120927609 · Cited by 63 · see citing works
Diamond, M. L., Ritter, A. C., Jackson, E. K., Conley, Y. P., Kochanek, P. M., Boison, D., & Wagner, A. K. (2015) · Epilepsia · doi:10.1111/epi.13044 · Cited by 69 · see citing works
Adenosine Receptors in Cerebral Ischemia
Melani, A., Pugliese, A. M., & Pedata, F. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00013-1 · Cited by 69 · see citing works
Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69 · see citing works
Rosito, M., Deflorio, C., Limatola, C., & Trettel, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4046-11.2012 · Cited by 68 · see citing works
Borroto‐Escuela, D. O., Hinz, S., Navarro, G., Franco, R., Müller, C. E., & Fuxé, K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00043 · Cited by 66 · see citing works
Thangudu, S., Cheng, F., & Su, C. (2020) · Polymers · doi:10.3390/polym12123055 · Cited by 64 · see citing works
Boia, R., Elvas, F., Madeira, M. H., Aires, I. D., Rodrigues‐Neves, A. C., Tralhão, P., Szabó, E. C., Baqi, Y., Müller, C. E., Tomé, Â. R., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.451 · Cited by 64 · see citing works
Self-citationPurinergic Signaling and Related Biomarkers in Depression
Bartoli, F., Burnstock, G., Crocamo, C., & Carrà, G. (2020) · Brain Sciences · doi:10.3390/brainsci10030160 · Cited by 64 · see citing works
Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61 · see citing works
GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics
Tang, T., Gong, T., Jiang, W., & Zhou, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.002 · Cited by 61 · see citing works
Zhou, Y., Zeng, X., Li, G., Yang, Q., Xu, J., Zhang, M., Mao, X., Cao, Y., Wang, L., Xu, Y., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14673 · Cited by 60 · see citing works
Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review
Chen, J. Q. A., Scheltens, P., Groot, C., & Ossenkoppele, R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201069 · Cited by 61 · see citing works
Purines and neuronal excitability: Links to the ketogenic diet
Masino, S. A., Kawamura, M., Ruskin, D. N., Geiger, J. D., & Boison, D. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.07.014 · Cited by 59 · see citing works
Köles, L., Kató, E., Hanuska, A., Zádori, Z., Al‐Khrasani, M., Zelles, T., Rubini, P., & Illés, P. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9480-5 · Cited by 59 · see citing works
The neuroprotective effects of an extract of Gastrodia elata
Tsai, C., Huang, C., Lin, Y., Lee, Y., Yang, Y.-C., & Huang, N. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.064 · Cited by 58 · see citing works
Adenosine transiently modulates stimulated dopamine release in the caudate–putamen via A1 receptors
Ross, A. E., & Venton, B. J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12946 · Cited by 58 · see citing works
Synaptic mechanisms of adenosine A2A receptor‐mediated hyperexcitability in the hippocampus
Rombo, D. M., Newton, K., Nissen, W., Badurek, S., Horn, J. M., Minichiello, L., Jefferys, J. G. R., Sebastião, A. M., & Lamsa, K. P. (2014) · Hippocampus · doi:10.1002/hipo.22392 · Cited by 56 · see citing works
Jiaojiao, Z., Fen, W., Liu, K., Qing, L., Ying, Y., & Dong, C. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8899-3 · Cited by 56 · see citing works
Ferreira, S. G., Gonçalves, F. Q., Marques, J. M., Tomé, Â. R., Rodrigues, R. J., Nunes‐Correia, I., Ledent, C. A., Harkany, T., Venance, L., Cunha, R. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12970 · Cited by 55 · see citing works
Self-citationHu, Q., Ren, X., Liu, Y., Li, Z., Zhang, L., Chen, X., He, C., & Chen, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.040 · Cited by 55 · see citing works
The role of microglia in the progression of glaucomatous neurodegeneration- a review
Zeng, H.-L., & Shi, J. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.22 · Cited by 55 · see citing works
Targeting with nanoparticles for the therapeutic treatment of brain diseases
Jin, G., Chakraborty, A., Lee, J., Knowles, J. C., & Kim, H. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731419897460 · Cited by 55 · see citing works
Hung, Y., Hung, S., Wu, Y., Wong, L.-K., Lai, M.-T., Shih, Y., Lee, T., & Lin, Y.-Y. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.016 · Cited by 54 · see citing works
Simões, A. P., Duarte, J. A., Agasse, F., Canas, P. M., Tomé, Â. R., Agostinho, P. M., & Cunha, R. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-204 · Cited by 54 · see citing works
Self-citationPoleszak, E., Szopa, A., Bogatko, K., Wyska, E., Wośko, S., Świąder, K., Doboszewska, U., Właź, A., Wróbel, A., Właź, P., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9959-2 · Cited by 54 · see citing works
Targeting adenosine A2A receptor antagonism for treatment of cancer
Congreve, M., Brown, G. A., Borodovsky, A., & Lamb, M. L. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1534825 · Cited by 54 · see citing works
Deb, P. K., Deka, S., Borah, P., Abed, S. N., & Klotz, K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716100509 · Cited by 54 · see citing works
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists
Navia, A. M., Ben, D. D., Lambertucci, C., Spinaci, A., Volpini, R., Marques-Morgado, I., Coelho, J. E., Lopes, L. V., Marucci, G., & Buccioni, M. (2020) · Cells · doi:10.3390/cells9071739 · Cited by 53 · see citing works
Kaster, M. P., Budni, J., Gazal, M., Cunha, M. P., Santos, A. R. S., & Rodrigues, A. L. S. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9361-8 · Cited by 52 · see citing works
Self-citationLeón, B. E., Kang, S., Franca-Solomon, G., Shang, P., & Choi, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.778456 · Cited by 52 · see citing works
Chiang, S., Liang, Z., Wang, Y.-C., & Liang, C.-H. (2017) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2017.03.007 · Cited by 51 · see citing works
Astrocytic Calcium and cAMP in Neurodegenerative Diseases
Sobolczyk, M., & Boczek, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.889939 · Cited by 50 · see citing works
Marisco, P. C., Carvalho, F. B., da Rosa, M. M., Girardi, B., Gutierres, J. M., Jaques, J. A., Salla, A. P. S., Pimentel, V. C., Schetinger, M. R. C., Leal, D. B. R., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1072-6 · Cited by 50 · see citing works
Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish
Bortolotto, J. W., de Melo, G. M., Cognato, G. D. P., Vianna, M. R. M. R., & Bonan, C. D. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.11.016 · Cited by 50 · see citing works
Borroto‐Escuela, D. O., & Fuxé, K. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01969-2 · Cited by 48 · see citing works
Pharmacological Management of Apathy in Dementia
Azhar, L., Kusumo, R. W., Marotta, G., Lanctôt, K., & Herrmann, N. (2022) · CNS Drugs · doi:10.1007/s40263-021-00883-0 · Cited by 39 · see citing works
Bartoli, F., Crocamo, C., Dakanalis, A., Brosio, E., Miotto, A., Capuzzi, E., Clerici, M., & Carrà, G. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.09.011 · Cited by 48 · see citing works
D’souza, A. A., Nozohouri, S., Bleier, B. S., & Amiji, M. M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03433-5 · Cited by 47 · see citing works
George, J., Gonçalves, F. Q., Cristóvão, G., Rodrigues, L., Meyer‐Fernandes, J. R., Gonçalves, T., Cunha, R. A., & Gomes, C. A. (2015) · Glia · doi:10.1002/glia.22833 · Cited by 47 · see citing works
Self-citationGonçalves, F. Q., Pires, J., Pliássova, A., Beleza, R. O., Lemos, C., Marques, J. M., Rodrigues, R. J., Canas, P. M., Köfalvi, A., Cunha, R. A., et al. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12851 · Cited by 47 · see citing works
Self-citationAdenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity
Sandau, U. S., Colino-Oliveira, M., Jones, A., Saleumvong, B., Coffman, S. Q., Liu, L., Miranda‐Lourenço, C., Palminha, C., Batalha, V. L., Xu, Y., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2146-16.2016 · Cited by 47 · see citing works
Shah, F. A., Park, D.-J., & Koh, P. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2576-x · Cited by 47 · see citing works
- Authors
- Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Cunha, Rodrigo A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 1808
- Issue
- 5
- Pages
- 1380-1399
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2081196843
- Cited by
- 419
- References
- 473
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 15 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 30 · 2016: 27 · 2015: 38 · 2014: 32 · 2013: 22 · 2012: 26
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, neuroprotection, neurodegeneration, neuromodulation, glutamatergic synapses, synaptic plasticity, ischemia, epilepsy, Parkinson's disease, Alzheimer's disease, neuroinflammation, neuron-glia communication, neurogenesis, growth factors, mental illness, adenosine receptor agonists
- MeSH terms
- Animals, Brain Diseases, Humans, Nerve Degeneration, Receptors, Purinergic P1, Neurotransmitter Agents, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review